Ontario Bioscience Innovation Organization (OBIO)
Receive up to $250,000 in Potential Funding.
The Ontario Bioscience Innovation Organization (OBIO) is an Ontario not-for-profit membership-based organization that strives to help further the commercialization of Ontario’s human health science. The prominent program available via the OBIO right now is the Capital Access Advisory Program (CAAP).
Ontario Bioscience Innovation Organization (OBIO)
Amount of Funding
Capital Access Advisory Program:
Your company’s pitch to investors at the OBIO Investment Summit will determine the amount of funding your company receives from the Capital Access Advisory Program.

Ontario Bioscience Innovation Organization (OBIO)
Eligible Applicants
Capital Access Advisory Program:
- A private, promising health science company in Ontario;
- Developing human health products in therapeutics, medical devices, diagnostics, or digital health tech;
- Has closed or is about to close a “seed” investment within six months;
- Intent on raising series A financing in 2022 to 2023;
- Has enough resources and funding runway to reach next key value inflection points to allow for their Series A raise; and
- Is a company that would benefit substantially from coaching/participating in CAAP to advance their business strategy and raise capital.

Ontario Bioscience Innovation Organization (OBIO)
Company Benefits
Capital Access Advisory Program:
- Receive guidance from international Steering Committee of investors, healthcare executives, and business experts on strategy for a successful raise;
- Access to a network of advisors with expertise in technology commercialization, business development, fundraising and negotiations; and
- Investor readiness, targeting and introductions.

Ontario Bioscience Innovation Organization (OBIO)
Program Deadline
Capital Access Advisory Program:
The deadline for applications is September 16th, 2022.
